Want to see IN:BALAXI full AI Analyst Report?

Balaxi Pharmaceuticals Limited (BALAXI) Financial Statements

0 Followers

Balaxi Pharmaceuticals Limited Financial Overview

Balaxi Pharmaceuticals Limited's market cap is currently ₹1.23B. The company's EPS TTM is ₹0.26; its P/E ratio is 49.51; and it has a dividend yield of 0.70%. Balaxi Pharmaceuticals Limited is scheduled to report earnings on August 5, 2026, and the estimated EPS forecast is ₹―. See an overview of income statement, balance sheet, and cash flow financials.

	Mar 26	Mar 25	Mar 24	Mar 23	Mar 22
Income Statement
Total Revenue	₹ 2.73B	₹ 2.89B	₹ 2.41B	₹ 3.36B	₹ 2.79B
Gross Profit	₹ 1.14B	₹ 1.27B	₹ 1.13B	₹ 1.34B	₹ 837.91M
Operating Income	₹ 52.93M	₹ 363.99M	₹ 467.31M	₹ 586.30M	₹ 503.11M
EBITDA	₹ 74.45M	₹ 305.64M	₹ 456.59M	₹ 603.82M	₹ 560.20M
Net Income	₹ 14.17M	₹ 250.70M	₹ -23.87M	₹ 459.63M	₹ 476.58M
Balance Sheet
Cash & Short-Term Investments	₹ 145.59M	₹ 394.00M	₹ 622.91M	₹ 282.17M	₹ 71.93M
Total Assets	₹ 3.37B	₹ 3.10B	₹ 2.58B	₹ 2.40B	₹ 1.76B
Total Debt	₹ 576.49M	₹ 534.25M	₹ 194.04M	₹ 133.06M	₹ 36.38M
Net Debt	₹ 430.90M	₹ 140.26M	₹ -428.87M	₹ -149.10M	₹ -35.55M
Total Liabilities	₹ 879.53M	₹ 786.06M	₹ 569.79M	₹ 567.89M	₹ 633.07M
Stockholders' Equity	₹ 2.49B	₹ 2.32B	₹ 2.01B	₹ 1.83B	₹ 1.13B
Cash Flow
Free Cash Flow	₹ -451.69M	₹ -589.01M	₹ 32.97M	₹ -89.05M	₹ 68.00M
Operating Cash Flow	₹ -82.44M	₹ -377.82M	₹ 48.66M	₹ 60.75M	₹ 341.44M
Investing Cash Flow	₹ -207.79M	₹ -217.64M	₹ -10.46M	₹ -105.65M	₹ -284.48M
Financing Cash Flow	₹ 41.82M	₹ 366.55M	₹ 302.54M	₹ 255.13M	₹ -1.63M

Currency in INR

Balaxi Pharmaceuticals Limited Earnings and Revenue History

Income Statement >

Balaxi Pharmaceuticals Limited Debt to Assets

Balance Sheet >

Balaxi Pharmaceuticals Limited Cash Flow

Cash Flow >

Balaxi Pharmaceuticals Limited Forecast EPS vs Actual EPS

Earnings >